Albion Sues TriGen Over Iron Supplement Patent

Law360, New York (September 28, 2009, 2:55 PM EDT) -- TriGen Laboratories Inc. has been accused by rival pharmaceutical company Albion Laboratories Inc. of infringing a mineral supplement patent and creating a defective product that by association has sullied Albion's reputation in the sphere of mineral chelates.

In a suit filed in the U.S. District Court for the District of Utah on Friday, Albion and Breckenridge Pharmaceutical Inc. — Albion's licensed generics distributor — allege that TriGen has introduced several products that it has represented to be equivalents of Albion and Breckenridge iron absorption supplements without...
To view the full article, register now.